Iovance Grants New Equity Awards to Recently Hired Employees

Iovance Biotherapeutics has made a significant corporate announcement, detailing the issuance of new stock options. This move directly impacts the company’s equity structure and is designed as an incentive for new hires.

The biotech firm confirmed on September 18 that it awarded these options under its inducement award program. The grants were approved for two new, non-executive employees joining the company.

The specific details of the award are as follows:
* The options cover a total of 22,810 shares of common stock.
* Each option carries an exercise price of $2.20 per share.
* This price is equivalent to the stock’s closing price on the grant date.

Compliance and Long-Term Incentive... Read more...